U.S. Life Sciences Stock News

Key Insights The considerable ownership by individual investors in Richtech Robotics indicates that they collectively...

Oceaneering International announced that its Marine Services Division was awarded an indefinite-delivery/indefinite-quantity contract by the Naval Supply Systems Command Weapon Systems Support, worth up to US$86 million over two years with three additional option years, to repair valves and actuators for U.S. Navy Virginia-class and Los Angeles-class submarines. This contract highlights Oceaneering’s expanding role in U.S. defense logistics, adding multi-year revenue visibility outside of...

Deciding what to do with your Zoom Communications stock these days feels a little like trying to tune in to the right frequency, with so many signals flying around. After the wild swings of recent years, you might be wondering if now is the right time to buy, hold, or even walk away. The stock price, lately hovering around $73, has been on a bit of a roller coaster, down just over 10% year-to-date, but up about 7.5% in the past year. That back-and-forth movement says a lot about shifting...

Some Eton Pharmaceuticals, Inc. ( NASDAQ:ETON ) shareholders may be a little concerned to see that the CFO, Treasurer...

CG Oncology, Inc. announced earnings results for the second quarter and first half of 2025, reporting a net loss of US$41.43 million for the quarter and US$75.88 million for the six months ended June 30, both sharply higher than a year earlier. The company's basic loss per share from continuing operations also increased substantially, highlighting escalating expenses or investment as a key theme in its financial performance. We'll explore how the increased net loss and rising loss per share...

Precigen announced that the US FDA has granted full approval to PAPZIMEOS, the first and only therapy approved for adults with recurrent respiratory papillomatosis (RRP), following positive pivotal clinical trial results showing durable complete responses. This milestone positions PAPZIMEOS as a potential new standard of care for a rare disease previously managed primarily with repeated surgeries lacking curative benefit. We'll explore how the full FDA approval of PAPZIMEOS for RRP reshapes...

We wouldn't blame Ralph Lauren Corporation ( NYSE:RL ) shareholders if they were a little worried about the fact that...

On August 14, 2025, Amcor plc announced fourth quarter 2025 results, reporting US$5.08 billion in sales and a US$39 million net loss, compared to US$3.54 billion in sales and US$257 million in net income a year prior. Despite increased sales, the company experienced a swing to a net loss but chose to continue its quarterly dividend payment of US$0.1275 per share. We’ll explore how Amcor’s swing to a quarterly net loss, despite strong sales, impacts the company’s investment narrative. Explore...

On August 19, 2025, Sociedad Química y Minera de Chile S.A. reported that its second quarter sales and net income had declined meaningfully compared to the previous year, with net income dropping to US$88.4 million from US$213.6 million and revenue falling to US$1,042.7 million from US$1,293.6 million. An interesting aspect is that, despite the year-over-year declines in profitability for the quarter, the company turned a net profit for the first half of 2025 compared to a large net loss in...

Earlier this week, Powell Industries announced a US$12.4 million investment to expand the production capacity at its Jacintoport manufacturing facility in Houston, increasing yard space by 62% and doubling shoreline bulkhead length for greater project flexibility. This expansion brings Powell’s total investment in Houston facilities to nearly US$40 million over eight years, strengthening its ability to serve Oil & Gas clients while providing adaptability for other sectors. We’ll now explore...

If you are watching Abbott Laboratories (ABT) this week, the stock’s recent run-up might have you wondering if there is a new story unfolding. There is no single headline or corporate event moving shares, but the persistent climb in its price is starting to draw more investor attention. When a stock like Abbott moves higher without a big, clear-cut catalyst, it often prompts investors to dig deeper into what is really driving sentiment, especially with economic uncertainty still present in...

With the business potentially at an important milestone, we thought we'd take a closer look at Achieve Life Sciences...

Investors may wish to note that the Executive VP & CFO of CS Disco, Inc. , Michael Lafair, recently netted US$72k from...

Thinking about what to do with Plug Power stock? You are not alone. With eye-popping short-term moves and nerve-wracking long-term slides, Plug Power’s stock has kept traders and investors on their toes. Just this past quarter, shares nearly doubled, climbing 97%, which stands out against the rougher ride over the last few years. With the price currently at $1.54 and still discounted about 28% compared to analyst targets, it is clear that expectations are shifting rapidly in both...

If you have ever found yourself staring at Conagra Brands’ stock chart and debating your next move, you are not alone. The consumer staples giant, trading under the ticker symbol CAG, has certainly given investors a lot to think about lately. After a choppy year, the stock recently closed at $19.30, down just under 1% over the last month and more than 30% year-to-date. Longer-term performance tells a similar story, with the one-year total return sitting at -33% and five-year total return near...

In recent weeks, Charter Communications and certain senior executives have faced multiple class action lawsuits alleging violations of federal securities laws, primarily concerning disclosures related to customer declines following the end of the FCC’s Affordable Connectivity Program (ACP). These legal challenges point to concerns about the accuracy and timeliness of management’s statements regarding the company’s operational outlook and financial performance. The lawsuits center on claims...

If you have been eyeing Kyndryl Holdings and wondering whether now is the right moment to buy, hold, or even reconsider your strategy, you are not alone. The company's stock has seen some dramatic swings lately, stirring up plenty of debate among investors trying to make sense of its momentum. Over the past year, Kyndryl’s stock is up more than 30%, which is impressive, especially when compared to some of its peers. However, shorter-term moves have been more volatile, with a 1-day gain of...

Monolithic Power Systems (MPWR) has seen a fresh wave of attention after its stock dipped slightly, closing 0.7% lower yesterday. While there is no headline-making news or AI announcement fueling the move, any quick turn in share price tends to stir up questions, especially with how dynamic the semiconductor sector has felt lately. For investors on the fence, even modest drops in a quality name like this can feel like either a warning sign or a window of opportunity. Taking a broader view,...

Let's talk about the popular Graco Inc. ( NYSE:GGG ). The company's shares had a relatively subdued couple of weeks in...

We wouldn't blame Alico, Inc. ( NASDAQ:ALCO ) shareholders if they were a little worried about the fact that Henry...

Graphic Packaging Holding Company's ( NYSE:GPK ) price-to-earnings (or "P/E") ratio of 12.7x might make it look like a...

Some Trustmark Corporation ( NASDAQ:TRMK ) shareholders may be a little concerned to see that the Chairman, Gerard...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

With a price-to-earnings (or "P/E") ratio of 49.3x Sonoco Products Company ( NYSE:SON ) may be sending very bearish...